Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $4,979 - $5,620
26 Added 0.28%
9,410 $2 Million
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $553,725 - $608,643
2,951 Added 45.87%
9,384 $1.81 Million
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $29,218 - $46,505
229 Added 3.69%
6,433 $1.3 Million
Q4 2022

Feb 21, 2023

BUY
$117.37 - $139.17 $67,487 - $80,022
575 Added 10.21%
6,204 $797,000
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $1,082 - $1,440
8 Added 0.14%
5,629 $771,000
Q2 2022

Aug 04, 2022

BUY
$108.81 - $179.33 $246,889 - $406,899
2,269 Added 67.69%
5,621 $994,000
Q1 2022

May 09, 2022

SELL
$119.61 - $157.85 $13,755 - $18,152
-115 Reduced 3.32%
3,352 $482,000
Q4 2021

Feb 03, 2022

BUY
$142.57 - $190.86 $86,825 - $116,233
609 Added 21.31%
3,467 $536,000
Q3 2021

Nov 15, 2021

BUY
$142.45 - $169.82 $286,751 - $341,847
2,013 Added 238.22%
2,858 $485,000
Q2 2021

Aug 13, 2021

SELL
$135.08 - $161.1 $63,217 - $75,394
-468 Reduced 35.64%
845 $133,000
Q1 2021

May 14, 2021

SELL
$137.51 - $190.8 $77,280 - $107,229
-562 Reduced 29.97%
1,313 $183,000
Q4 2020

Feb 12, 2021

BUY
$164.63 - $211.93 $308,681 - $397,368
1,875 New
1,875 $328,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.